CME Group to Post Q2 2018 Earnings of $1.64 Per Share, Jefferies Group Forecasts (CME)

CME Group (NASDAQ:CME) – Research analysts at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of CME Group in a research report issued on Tuesday, April 10th. Jefferies Group analyst D. Fannon expects that the financial services provider will earn $1.64 per share for the quarter. Jefferies Group also issued estimates for CME Group’s Q3 2018 earnings at $1.60 EPS, Q4 2018 earnings at $1.57 EPS, FY2018 earnings at $6.65 EPS and FY2019 earnings at $6.87 EPS.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 earnings per share.



Other analysts have also issued reports about the stock. Barclays lifted their price target on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price target on shares of CME Group in a research note on Friday, February 2nd. Citigroup reiterated a “buy” rating and issued a $172.00 price target (up from $155.00) on shares of CME Group in a research note on Monday, January 29th. Bank of America lifted their price target on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, February 2nd. Finally, BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 10th. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $165.57.

Shares of CME Group stock opened at $164.21 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03. The stock has a market capitalization of $54,890.48, a price-to-earnings ratio of 33.88, a PEG ratio of 2.21 and a beta of 0.56. CME Group has a 52-week low of $114.82 and a 52-week high of $171.71.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. ARK Investment Management LLC bought a new stake in CME Group during the fourth quarter valued at approximately $120,000. Valeo Financial Advisors LLC bought a new stake in CME Group during the third quarter valued at approximately $124,000. AlphaOne Investment Services LLC bought a new stake in CME Group during the fourth quarter valued at approximately $146,000. Mosaic Family Wealth LLC bought a new stake in CME Group during the fourth quarter valued at approximately $146,000. Finally, Truewealth LLC bought a new stake in CME Group during the fourth quarter valued at approximately $157,000. Institutional investors own 83.12% of the company’s stock.

In related news, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the completion of the sale, the insider now directly owns 40,153 shares in the company, valued at $6,491,133.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Leo Melamed sold 7,300 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $155.78, for a total transaction of $1,137,194.00. Following the sale, the director now owns 10,537 shares of the company’s stock, valued at $1,641,453.86. The disclosure for this sale can be found here. Insiders have sold 35,699 shares of company stock valued at $5,532,362 over the last 90 days. 0.57% of the stock is currently owned by company insiders.

The firm also recently announced a quarterly dividend, which was paid on Monday, March 26th. Investors of record on Friday, March 9th were given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.71%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date was Thursday, March 8th. CME Group’s payout ratio is 58.70%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://dakotafinancialnews.com/2018/04/13/cme-group-to-post-q2-2018-earnings-of-1-64-per-share-jefferies-group-forecasts-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply